ABVC BIOPHARMA, INC. Quarterly Return On Assets in % from Q1 2012 to Q1 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Abvc Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q1 2024.
  • Abvc Biopharma, Inc. Return On Assets for the quarter ending March 31, 2024 was -92 %, a 16.3% increase year-over-year.
  • Abvc Biopharma, Inc. annual Return On Assets for 2023 was -82.3 %, a 42.5% increase from 2022.
  • Abvc Biopharma, Inc. annual Return On Assets for 2022 was -143 %, a 26.8% decline from 2021.
  • Abvc Biopharma, Inc. annual Return On Assets for 2021 was -113 %, a 16.9% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2024 -92 +17.9 +16.3% Jan 1, 2024 Mar 31, 2024
Q4 2023 -82.3 +60.8 +42.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -106 +49.2 +31.6% Jul 1, 2023 Sep 30, 2023
Q2 2023 -126 +8.88 +6.57% Apr 1, 2023 Jun 30, 2023
Q1 2023 -110 +40 +26.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 -143 -30.3 -26.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -155 -63.7 -69.6% Jul 1, 2022 Sep 30, 2022
Q2 2022 -135 -25.9 -23.7% Apr 1, 2022 Jun 30, 2022
Q1 2022 -150 -30.5 -25.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -113 +22.9 +16.9% Oct 1, 2021 Dec 31, 2021
Q3 2021 -91.6 +9.96 +9.81% Jul 1, 2021 Sep 30, 2021
Q2 2021 -109 -22.6 -26.1% Apr 1, 2021 Jun 30, 2021
Q1 2021 -119 -57.3 -92.3% Jan 1, 2021 Mar 31, 2021
Q4 2020 -136 -81.3 -149% Oct 1, 2020 Dec 31, 2020
Q3 2020 -102 -4.95 -5.13% Jul 1, 2020 Sep 30, 2020
Q2 2020 -86.6 +19 +18% Apr 1, 2020 Jun 30, 2020
Q1 2020 -62.1 +71.5 +53.5% Jan 1, 2020 Mar 31, 2020
Q4 2019 -54.4 +122 +69.2% Oct 1, 2019 Dec 31, 2019
Q3 2019 -96.6 -0.13 -0.14% Jul 1, 2019 Sep 30, 2019
Q2 2019 -106 +91.3 +46.4% Apr 1, 2019 Jun 30, 2019
Q1 2019 -134 +103 +43.4% Jan 1, 2019 Mar 31, 2019
Q4 2018 -177 +131 +42.7% Oct 1, 2018 Dec 31, 2018
Q3 2018 -96.5 +468 +82.9% Jul 1, 2018 Sep 30, 2018
Q2 2018 -197 +1.46K +88.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 -236 +1.16K +83.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -308 +2.35K +88.4% Oct 1, 2017 Dec 31, 2017
Q3 2017 -564 +3.08K +84.5% Jul 1, 2017 Sep 30, 2017
Q2 2017 -1.66K +448 +21.3% Apr 1, 2017 Jun 30, 2017
Q1 2017 -1.4K +678 +32.7% Jan 1, 2017 Mar 31, 2017
Q4 2016 -2.66K -1.39K -109% Oct 1, 2016 Dec 31, 2016
Q3 2016 -3.65K -3.54K -3356% Jul 1, 2016 Sep 30, 2016
Q2 2016 -2.11K -2.07K Apr 1, 2016 Jun 30, 2016
Q1 2016 -2.07K -2.05K Jan 1, 2016 Mar 31, 2016
Q4 2015 -1.27K -1.25K Oct 1, 2015 Dec 31, 2015
Q3 2015 -106 -93.3 -764% Jul 21, 2015 Sep 30, 2015
Q2 2015 -37.1* -108 Apr 1, 2015 Jun 30, 2015
Q1 2015 -21.5* -38.2 Jan 1, 2015 Mar 31, 2015
Q4 2014 -16.3* +20.9 Oct 1, 2014 Dec 31, 2014
Q3 2014 -12.2 +98.3 +88.9% Jul 1, 2014 Sep 30, 2014
Q2 2014 71.1* +280 Apr 1, 2014 Jun 30, 2014
Q1 2014 16.7* +252 Jan 1, 2014 Mar 31, 2014
Q4 2013 -37.2* +267 Oct 1, 2013 Dec 31, 2013
Q3 2013 -110 +219 +66.4% Jul 1, 2013 Sep 30, 2013
Q2 2013 -209 +184 +46.8% Apr 1, 2013 Jun 30, 2013
Q1 2013 -235 +314 +57.2% Jan 1, 2013 Mar 31, 2013
Q4 2012 -305 Oct 1, 2012 Dec 31, 2012
Q3 2012 -329 Jul 1, 2012 Sep 30, 2012
Q2 2012 -392 Apr 1, 2012 Jun 30, 2012
Q1 2012 -549 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.